Cytomedix gets funding support from Maryland Venture Fund

04/5/2013 | BeckersASC.com

Cytomedix has secured a $500,000 investment from the Maryland Venture Fund. The regenerative medicine company is currently working on its AutoloGel System, which uses platelet-rich plasma for wound healing. The company also manufactures the Angel Whole Blood Separation System, which is used in orthopedic and surgical procedures.

View Full Article in:

BeckersASC.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA